Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

A simple test of choice stepping reaction time for assessing fall risk in people with multiple sclerosis.
Phase 3 Efficacy and Tolerability Study of OnabotulinumtoxinA for Urinary Incontinence From Neurogenic Detrusor Overactivity.
Comparison of Point Estimates and Average Thicknesses of Retinal Layers Measured Using Manual Optical Coherence Tomography Segmentation for Quantification of Retinal Neurodegeneration in Multiple Sclerosis.
Neuroborreliosis during natalizumab treatment in multiple sclerosis.
Autoantibody biomarkers in childhood-acquired demyelinating syndromes: results from a national surveillance cohort.
Cutting Edge: MicroRNA-223 Regulates Myeloid Dendritic Cell-Driven Th17 Responses in Experimental Autoimmune Encephalomyelitis.
Sexual dysfunction in multiple sclerosis: A 6-year follow-up study.
The new therapeutic landscape in multiple sclerosis: exciting times and new perspectives.
Novel replication-competent circular DNA molecules from healthy cattle serum and milk and multiple sclerosis-affected human brain tissue.
Progesterone alleviates neural behavioral deficits and demyelination with reduced degeneration of oligodendroglial cells in cuprizone-induced mice.
MMP-9 in Translation: From Molecule to Brain Physiology, Pathology and Therapy.
Natalizumab treatment for multiple sclerosis inducing a toxic acute myocardial damage. Is there any relationship?
Beneficial effects of UV radiation other than via vitamin D production.
Oxidative tissue injury in multiple sclerosis is only partly reflected in experimental disease models.
Sacral nerve stimulation for neurogenic bladder.
Downbeat nystagmus associated with damage to the medial longitudinal fasciculus of the pons: A vestibular balance control mechanism via the lower brainstem paramedian tract neurons.
Contrast enrichment of spinal cord MR imaging using a ratio of T1-weighted and T2-weighted signals.
Modulators of Microglia: a Patent Review.
Scope and Applications of Nanomedicines for the Management of Multiple Sclerosis.
An update on new and emerging therapies for relapsing-remitting multiple sclerosis.
How type I interferons shape myeloid cell function in CNS autoimmunity.
What do healthcare providers advise women with multiple sclerosis regarding pregnancy?
Novel oxazolo-oxazole derivatives of FTY720 reduce endothelial cell permeability, immune cell chemotaxis and symptoms of experimental autoimmune encephalomyelitis in mice.
Evaluation of GABAergic Transmission Modulation as a Novel Functional Target for Management of Multiple Sclerosis: Exploring Inhibitory Effect of GABA on Glutamate-Mediated Excitotoxicity.
Risk-benefit considerations in the treatment of relapsing-remitting multiple sclerosis.

Pages